D. Boral Capital reaffirmed their buy rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. D. Boral ...

Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of OmniAb in a report released on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now ...

Notable insider trades include Schobel Alexander Mark, Chief Innovation/Tech Officer at Aquestive Therapeutics Inc (AQST), who sold 50000 shares on Mar 15 ’24, at $6 each, totaling $0.30 million. On ...

Envista Holdings Corp (NVST) stock saw a decline, ending the day at $19.17 which represents a decrease of $-0.32 or -1.64% from the prior close of $19.49. The stock opened at $19.42 and touched a low ...

Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...